Showing 161 - 180 results of 696 for search '"ClinicoEconomics and Outcomes Research"', query time: 0.22s Refine Results
  1. 161
    Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  2. 162
    Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  3. 163
    A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States
    by Zhang W, Amos TB, Gutkin SW, Lodowski N, Giegerich E, Joshi K
    Published 2018-06-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  4. 164
    Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  5. 165
    Antibiotic expected effectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in Spain
    by Grau S, Lozano V, Valladares A, Cavanillas R, Xie Y, Nocea G
    Published 2014-02-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  6. 166
    Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  7. 167
    A potential gender bias in assessing quality of life – a standard gamble experiment among university students
    by Al Obaidi L, Mahlich J
    Published 2015-04-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  8. 168
    Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea
    by Tremblay G, Majethia U, Breeze JL, Kontoudis I, Park J
    Published 2016-09-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  9. 169
    Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
    by Mencacci C, Di Sciascio G, Katz P, Ripellino C
    Published 2013-02-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  10. 170
    Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)
    by Chien C-R, Shih Y-C
    Published 2012-07-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  11. 171
    Management strategies and cost effectiveness in the prevention of cervical cancer
    by Smita R Prasad
    Published 2009-06-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  12. 172
    Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings
    by Trocio J, Rosen VM, Gupta A, Dina O, Vo L, Hlavacek P, Rosenblatt L
    Published 2018-12-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  13. 173
    Relative cost-effectiveness of an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Italy
    by Guest JF, Panca M, Ovcinnikova O, Nocerino R
    Published 2015-06-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  14. 174
    Indirect costs associated with premature mortality among those with veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan dysfunction post-hematopoietic stem-cell-transplant
    by Zhou ZY, Tang W, Villa KF
    Published 2018-12-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  15. 175
    Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  16. 176
    Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units
    by Perrone V, Sangiorgi D, Buda S, Degli Esposti L
    Published 2017-03-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  17. 177
    Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  18. 178
    Challenges in measuring and valuing productivity costs, and their relevance in mood disorders
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  19. 179
    Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis
    by Dranitsaris G, Shane LG, Crowther M, Feugere G, Woodruff S
    Published 2017-01-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
  20. 180
    Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA
    by Billings LK, Mocarski M, Basse A, Hunt B, Valentine WJ, Jodar E
    Published 2019-03-01
    “...ClinicoEconomics and Outcomes Research...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search